Literature DB >> 15466922

Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-gamma-producing lymphocytes and IL-6- and TNF-alpha-producing macrophages.

An D Billiau1, Tania Roskams, Rita Van Damme-Lombaerts, Patrick Matthys, Carine Wouters.   

Abstract

Macrophage activation syndrome (MAS) is a rare and potentially fatal disorder, thought to result from uncontrolled activation and proliferation of T cells and excessive activation of macrophages. The term MAS designates a clinicopathologic entity that occurs in different hemophagocytic syndromes (HSs). Primary hemophagocytic lymphohistiocytosis (HLH) is recognized to have an immunogenetic basis, but in the secondary HS (also referred to as secondary HLH), the cause is unknown. The pathogenesis of the accelerated disease phase typical of MAS remains incompletely understood. This report describes the immunohistochemical findings on liver tissues from 5 children, each of whom presented with MAS in the context of a different type of HS. The data provide direct evidence for the involvement of activated CD8(+) lymphocytes through the production of interferon-gamma and of macrophages through hemophagocytosis and production of interleukin 6 and tumor necrosis factor-alpha, and underscore the view that MAS in different HSs share a common effector pathway.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15466922     DOI: 10.1182/blood-2004-08-2997

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  75 in total

1.  Human CD19-Targeted Mouse T Cells Induce B Cell Aplasia and Toxicity in Human CD19 Transgenic Mice.

Authors:  Christopher A Pennell; Jessie L Barnum; Cameron S McDonald-Hyman; Angela Panoskaltsis-Mortari; Megan J Riddle; Zhengming Xiong; Michael Loschi; Govindarajan Thangavelu; Heather M Campbell; Meghan D Storlie; Yosef Refaeli; Scott N Furlan; Michael C Jensen; Leslie S Kean; Jeffrey S Miller; Jakub Tolar; Mark J Osborn; Bruce R Blazar
Journal:  Mol Ther       Date:  2018-04-07       Impact factor: 11.454

Review 2.  Hyperinflammation, rather than hemophagocytosis, is the common link between macrophage activation syndrome and hemophagocytic lymphohistiocytosis.

Authors:  Lehn K Weaver; Edward M Behrens
Journal:  Curr Opin Rheumatol       Date:  2014-09       Impact factor: 5.006

3.  Lymphocyte-independent pathways underlie the pathogenesis of murine cytomegalovirus-associated secondary haemophagocytic lymphohistiocytosis.

Authors:  E Brisse; M Imbrechts; T Mitera; J Vandenhaute; N Berghmans; L Boon; C Wouters; R Snoeck; G Andrei; P Matthys
Journal:  Clin Exp Immunol       Date:  2018-01-18       Impact factor: 4.330

4.  T-cell immunotherapy: looking forward.

Authors:  Jacqueline Corrigan-Curay; Hans-Peter Kiem; David Baltimore; Marina O'Reilly; Renier J Brentjens; Laurence Cooper; Stephen Forman; Stephen Gottschalk; Philip Greenberg; Richard Junghans; Helen Heslop; Michael Jensen; Crystal Mackall; Carl June; Oliver Press; Daniel Powell; Antoni Ribas; Steven Rosenberg; Michel Sadelain; Brian Till; Amy P Patterson; Robert C Jambou; Eugene Rosenthal; Linda Gargiulo; Maureen Montgomery; Donald B Kohn
Journal:  Mol Ther       Date:  2014-09       Impact factor: 11.454

Review 5.  Antibody-modified T cells: CARs take the front seat for hematologic malignancies.

Authors:  Marcela V Maus; Stephan A Grupp; David L Porter; Carl H June
Journal:  Blood       Date:  2014-02-27       Impact factor: 22.113

Review 6.  Adult-Onset Still's Disease: Molecular Pathophysiology and Therapeutic Advances.

Authors:  Paolo Sfriso; Sara Bindoli; Paola Galozzi
Journal:  Drugs       Date:  2018-08       Impact factor: 9.546

7.  Delayed addition of tumor necrosis factor (TNF) antagonists inhibits the generation of CD11c+ dendritic cells derived from CD34+ cells exposed to TNF-alpha.

Authors:  Yong-Mei Guo; Makoto Hirokawa; Naoto Takahashi; Masumi Fujishima; Naohito Fujishima; Atsushi Komatsuda; Hiroyuki Tagawa; Hideaki Ohyagi; Yoshihiro Michishita; Kumi Ubukawa; Miwa Hebiguchi; Weiguo Xiao; Kenichi Sawada
Journal:  Int J Hematol       Date:  2009-12-12       Impact factor: 2.490

8.  Pre- and post-natal treatment of hemophagocytic lymphohistiocytosis.

Authors:  Ami J Shah; Neena Kapoor; Robert M Cooper; Gay M Crooks; Carl Lenarsky; Hisham Abdel-Azim; Shi Qi Wu; Kathy Wilson; Kenneth I Weinberg; Robertson Parkman; Donald B Kohn
Journal:  Pediatr Blood Cancer       Date:  2009-01       Impact factor: 3.167

Review 9.  Bispecific Antibodies for the Treatment of Acute Myeloid Leukemia.

Authors:  Daniel G Guy; Geoffrey L Uy
Journal:  Curr Hematol Malig Rep       Date:  2018-12       Impact factor: 3.952

10.  Acute hepatitis in three patients with systemic juvenile idiopathic arthritis taking interleukin-1 receptor antagonist.

Authors:  Scott Canna; Jennifer Frankovich; Gloria Higgins; Michael R Narkewicz; S Russell Nash; J Roger Hollister; Jennifer B Soep; Leonard L Dragone
Journal:  Pediatr Rheumatol Online J       Date:  2009-12-22       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.